Skeletal muscle contractility and fatigability in adults with cystic fibrosis  Mathieu Gruet, Nicolas Decorte, Laurent Mely, Jean-Marc Vallier, Boubou.

Slides:



Advertisements
Similar presentations
Central and peripheral quadriceps fatigue in congestive heart failure
Advertisements

Recovery from fatigue of velocity-dependent power in young and old men Brian H Dalton, Geoffrey A Power, Anthony A Vandervoort (FACSM), and Charles L Rice.
Group III/IV locomotor muscle afferents alter motor cortical and corticospinal excitability and promote central fatigue during cycling exercise  Simranjit.
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Effects of ivacaftor on severely ill patients with cystic fibrosis carrying a G551D mutation  Helge Hebestreit, Annette Sauer-Heilborn, Rainald Fischer,
The prevalence of “risky behaviour” in adults with cystic fibrosis
Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus  Magnus Hillman, Leif Eriksson, Lena Mared, Karin Helgesson,
Zhumin Zhang, Suzanne M. Shoff, HuiChuan J. Lai 
Stimulated single-fiber electromyography (sSFEMG) in Lambert-Eaton syndrome  Vincenzo Todisco, Giovanni Cirillo, Rocco Capuano, Alessandro d'Ambrosio,
P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham 
The immediate effect of musculoskeletal physiotherapy techniques and massage on pain and ease of breathing in adults with cystic fibrosis  Annemarie Lee,
Is infection with hypermutable Pseudomonas aeruginosa clinically significant?  Adi Auerbach, Eitan Kerem, Marc Victor Assous, Elie Picard, Maskit Bar-Meir 
Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients  Karen.
Towards an individualized protocol for workload increments in cardiopulmonary exercise testing in children and adolescents with cystic fibrosis  H.J.
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
Abaigeal D. Jackson, Christopher H. Goss  Journal of Cystic Fibrosis 
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Katarine Egressy, Michaelene Jansen, Keith C. Meyer 
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Cirrhosis and other liver disease in cystic fibrosis
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
The ease of breathing test tracks clinical changes in cystic fibrosis
Use of the Peak Heart Rate Reached During Six-Minute Walk Test to Predict Individualized Training Intensity in Patients With Cystic Fibrosis: Validity.
Controlled clinical trials in cystic fibrosis — are we doing better?
Central and peripheral quadriceps fatigue in congestive heart failure
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Vitamin A and lung function in CF
A.H. Gifford  Journal of Cystic Fibrosis 
M. Wouthuyzen-Bakker, F.A.J.A. Bodewes, H.J. Verkade 
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009  Yolanda P. Lillquist,
Inhalation solutions — Which ones may be mixed
Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C
Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis  D.W. Reid, R. Latham, I.L.
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Determinants of dyspnea and alveolar hypoventilation during exercise in cystic fibrosis: Impact of inspiratory muscle endurance  Sylvie Leroy, Thierry.
Ultrasound and magnetic resonance imaging assessment of joint disease in symptomatic patients with cystic fibrosis arthropathy  G. Fitch, K. Williams,
Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J
Stenotrophomonas maltophilia in cystic fibrosis: Improved detection by the use of selective agar and evaluation of antimicrobial resistance  P. Goncalves-Vidigal,
Nasal polyposis in lung transplant recipients with cystic fibrosis
Absence of calf muscle metabolism alterations in active cystic fibrosis adults with mild to moderate lung disease  N. Decorte, M. Gruet, B. Camara, S.
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.
Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention  H. White, K. Pollard, C. Etherington, I. Clifton,
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis  Joseph M. Collaco, Karen S. Raraigh, Lawrence.
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Michael W. Konstan, David J. Pasta, Jeffrey S. Wagener, Donald R
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
CFTR modulators and pregnancy: Our work has only just begun
Beta-lactam allergy in adults with cystic fibrosis
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Anne K. Swisher, Kathryn Moffett, Linda Baer 
Cystic fibrosis and pregnancy in the modern era: A case control study
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience  C.R.
Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening  Fiona Cunningham, Sharon Lewis, Lisette.
Presentation transcript:

Skeletal muscle contractility and fatigability in adults with cystic fibrosis  Mathieu Gruet, Nicolas Decorte, Laurent Mely, Jean-Marc Vallier, Boubou Camara, Sébastien Quetant, Bernard Wuyam, Samuel Verges  Journal of Cystic Fibrosis  Volume 15, Issue 1, Pages e1-e8 (January 2016) DOI: 10.1016/j.jcf.2015.05.004 Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Schematic illustration of the neuromuscular protocol. Pre exercise neuromuscular evaluation consisted of two maximal voluntary contractions (MVC) with femoral nerve magnetic stimulations delivered at different frequencies in both contracted and relaxed muscle. See the text for the exact timing. This neuromuscular evaluation was repeated after each fatiguing set, at exhaustion (Exh) and after 10min of recovery (Post 10). The fatiguing task consisted of sets of 10 intermittent (5-s on/5-s off) isometric contractions at submaximal target force levels, starting at 10% MVC with increment of 10% MVC each set until exhaustion. Journal of Cystic Fibrosis 2016 15, e1-e8DOI: (10.1016/j.jcf.2015.05.004) Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 Changes in maximum voluntary contraction (MVC, panel A) and potentiated twitch amplitude (Twp, panel B) evoked by femoral nerve magnetic stimulation in the relaxed muscle at baseline (Pre), during the fatiguing task after each set, immediately after exhaustion (Exh) and after 10min of recovery (P10), in cystic fibrosis (CF) patients (MVC, n=15; Twp, n=13) and controls (MVC, n=15; Twp, n=13). * Time effect, significantly different from Pre (P<0.05); # Time effect, significant difference between Exh and P10 (P<0.05). Journal of Cystic Fibrosis 2016 15, e1-e8DOI: (10.1016/j.jcf.2015.05.004) Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions

Fig. 3 Changes in doublets at 100Hz (DB100, panel A), 10Hz (Db10, panel B), ratio between doublets at 10Hz and 100Hz (Db10:100, panel C) and maximal M-wave amplitude (Mmax, panel D) evoked by femoral nerve magnetic stimulation at baseline (Pre), during the fatiguing task after each set, immediately after exhaustion (Exh) and after 10min of recovery (P10), in cystic fibrosis (CF) patients (all n=12, except Mmax, n=13) and controls (all n=12, except Mmax, n=13). * Time effect, significantly different from Pre (P<0.05); # time effect, significant difference between Exh and P10 (P<0.05). Journal of Cystic Fibrosis 2016 15, e1-e8DOI: (10.1016/j.jcf.2015.05.004) Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions